Literature DB >> 18061968

Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab.

Heiner Appel1, Kay-Geert A Hermann, Christian E Althoff, Martin Rudwaleit, Joachim Sieper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18061968

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

1.  Recent advances in imaging in psoriatic arthritis.

Authors:  René Panduro Poggenborg; Lene Terslev; Susanne Juhl Pedersen; Mikkel Ostergaard
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

Review 2.  [Inflammatory spinal diseases: axial spondyloarthritis : Central importance of imaging].

Authors:  X Baraliakos; M Fruth; U Kiltz; J Braun
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

3.  Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging.

Authors:  Martina Karpitschka; Patrizia Godau-Kellner; Herbert Kellner; Annie Horng; Daniel Theisen; Christian Glaser; Bernhard Brandlhuber; Maximilian Reiser; Sabine Weckbach
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

Review 4.  Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics.

Authors:  Heiner Appel; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

5.  Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial.

Authors:  I-H Song; Kg Hermann; H Haibel; C E Althoff; Ce Althoff; J Listing; Gr Burmester; A Krause; M Bohl-Bühler; B Freundlich; M Rudwaleit; J Sieper
Journal:  Ann Rheum Dis       Date:  2011-04       Impact factor: 19.103

6.  Predictive Factors of Clinical Response of Infliximab Therapy in Active Nonradiographic Axial Spondyloarthritis Patients.

Authors:  Zhiming Lin; Zetao Liao; Jianlin Huang; Maixing Ai; Yunfeng Pan; Henglian Wu; Jun Lu; Shuangyan Cao; Li Li; Qiujing Wei; Deshen Tang; Yanlin Wei; Tianwang Li; Yuqiong Wu; Manlong Xu; Qiuxia Li; Ou Jin; Buyun Yu; Jieruo Gu
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.